Aryl aniline derivatives as β2 adrenergic receptor agonists
US7994165B2 · kind B2 · utility
0Cited by
27References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 6, 2009 |
| Grant date | Aug 9, 2011 |
| Priority date | — |
| Expiry date | Mar 19, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D265/30
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention provides novel β2 adrenergic receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with β2 adrenergic receptor activity, and processes and intermediates useful for preparing such compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.